CERCELL A/S: Financial statements 2014
CVR: 31940346
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
CERCELL A/S (CVR 31940346) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 250,261 and a net result of DKK 11,099 compared with DKK 2,160 the year before. That is a decrease of 46.6% compared with the year before. Equity in the 2014 report amounted to DKK 140,748. The solvency ratio was 13.2%.
- Gross Profit
- DKK 250,261
- Profit/Loss
- DKK 11,099
- Equity
- DKK 140,748
- Total Assets
- DKK 1,065,447
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 250 t. | 11 t. | 141 t. | - |
| 2013 | - | 469 t. | 2 t. | 130 t. | - |
| 2012 | - | 296 t. | 3 t. | 127 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
CERCELL A/S has published its annual report for 2013. Gross profit came to DKK 468,811, and the net result was DKK 2,160.
About CERCELL A/S
CERCELL A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2009. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named CERCELL ApS. The management consists of Kevin Robert Klejn and Flemming Petersen. The board consists of August Kisling Stobbe, Flemming Petersen and Per Stobbe. The company is owned by Stobbe GmbH. The company has 18 employees (2026). In 2025, the company reported a gross profit of DKK 10,765,334 and a net result of DKK 1,016,303 compared with DKK 425,117 the year before. Equity in the 2025 report amounted to DKK 10,726,399.